Rafael Figueroa Dugarte, MD
Colon & Rectal Surgery · Farmington, MONPI 1265699805
Payments from drug & device makers
What this record shows
This record is dominated by education: $8,500 of the $10,428 with a category attached, or 81.5%. Intuitive Surgical accounts for 93.9% of it on its own, with 4 other manufacturers making up the rest. 2025 is the largest year on record at $9,797, more than ten times the $572 reported in 2019.
Across 22 payments — averaging $474.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$10K
- Stryker$572
- Merck$23
- Boston Scientific$20
- Daiichi Sankyo Inc.$16
What the payments were for
- Travel & lodging$1,68016%
- Food & beverage$2482%
- Education$8,50082%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 18 | $9,797 |
| Stryker | 1 | $572 |
| Merck | 1 | $23 |
| Boston Scientific | 1 | $20 |
| Daiichi Sankyo Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DAVINCI XI$8,500
- Da Vinci Surgical System$940
- SPY TECHNOLOGY$572
- DERMACELL$572
How this compares
$10,428 in reported general payments places this provider in the 80th percentile of 36 colon & rectal surgery providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Omeprazole | 31 | $465 |
| Dicyclomine Hcl | 14 | $448 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 41 | $224 |
| Neomycin Sulfate | 12 | $68 |
| Metronidazole | 16 | $57 |
| Tramadol Hcl | 15 | $19 |
Paid to pharmacies, not to this prescriber.
Other colon & rectal surgery in Farmington
- Lawrence MendelowSaint Louis$234K
- Robert AmajoyiKansas City$56K
- Paul WiseSaint Louis$24K
- Donald SummersSaint Louis$22K
- Steven HuntSaint Louis$17K
- Tatiana Ramirez DominguezSaint Louis$12K
- Eric LedermanSaint Louis$11K
- Patrick ChizekSaint Louis$8K
- Alyssa WaitSaint Louis$6K
- Megan NicolasSpringfield$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.